INS and obesity disorder: It was reported that FFAR1-mediated acute insulin increasing effects coincide with chronic lipotoxic effects, such as impaired glucose homeostasis and hypoinsulinemia, with FFA1 receptor-deficient mice being protected against obesity-induced liver steatosis, hyperglycemia, glucose intolerance, and hyperinsulinemia [37].